Are we on the brink of a stem cell revolution? – Telegraph.co.uk
Telegraph.co.uk |
Are we on the brink of a stem cell revolution?
Telegraph.co.uk It has now been decades since stem cell technology emerged as the next great breakthrough in modern medicine, with the bold potential for one day curing everything from heart disease to cancer. Today, that optimism doesn’t appear to have diminished. It … |
Seeking Alpha |
Adverem Biotechnologies: Gene Therapy Company And Our New Buy
Seeking Alpha We bought shares of Adverem Biotechnologies (ADVM). The stock is at an attractive entry point ahead of phase I/II data from a gene therapy trial in alpha-1 antitrypsin deficiency in the second half of this year. We are rating the stock a Buy with price … Adverum Biotechnologies Inc. (ADVM) Plunges 6.03% on April 06Equities.com Analysts’ Weekly Ratings Changes for Adverum Biotechnologies (ADVM)Week Herald Adverum Biotechnologies (NASDAQ:ADVM) Downgraded to Hold at Zacks Investment ResearchStockNewsTimes |